Standard Operating Procedure for Tracking Labeling Commitments and Deadlines

Department	Regulatory Affairs
SOP No.	RA/2026/753
Supersedes	NA
Page No.	1 of X
Issue Date	15/04/2026
Effective Date	15/04/2026
Review Date	15/04/2028

Purpose

This SOP provides clear instructions for systematic tracking, monitoring, and management of all labeling commitments and deadlines arising from regulatory submissions, client agreements, and internal quality requirements. It ensures timely fulfillment of labeling obligations to maintain compliance with regulatory standards and avoid delays in product approval or market availability.

Scope

This SOP applies to all labeling commitments related to regulatory submissions, artwork approvals, product information updates, and labeling change controls across all pharmaceutical dosage forms and product lines handled by the Regulatory Affairs department. It covers tracking systems, documentation, communication with stakeholders, and review processes. Activities excluded include manufacturing execution and warehouse operations.

Responsibilities

The following roles are involved:

• Regulatory Affairs Executive: Identifies labeling commitments from submission documents and client communications.
• Regulatory Affairs Coordinator: Maintains the tracking system and updates deadlines.

<liQuality Assurance Reviewer: Verifies that commitments are recorded correctly and compliance is maintained.

• Regulatory Affairs Manager: Reviews and approves tracking reports and progress status.
• Document Control Specialist: Archives completed tracking records as per documentation policies.

Accountability

The Regulatory Affairs Head is accountable for the effective implementation, compliance to the SOP, escalations related to missed deadlines, periodic SOP review, and assessing overall effectiveness of the tracking process.

Procedure

1. Preparation and Prerequisites:

Ensure access to relevant regulatory submission dossiers, client agreements, labeling artwork files, prior commitment logs, and validated electronic tracking software or spreadsheets.

2. Identification of Labeling Commitments:

Upon receipt of submission approvals, client communications, or regulatory queries, Regulatory Affairs Executive must carefully extract all labeling-related commitments such as deadlines for artwork submissions, product information updates, or language translations.

3. Recording and Scheduling:

Each identified commitment shall be entered into the central tracking system with details including commitment description, responsible personnel, deadlines, associated product information, and linked documents. Deadlines must be set with appropriate lead times to allow review and approval cycles.

4. Communication and Follow-up:

Regulatory Affairs Coordinator will generate periodic reports (weekly or monthly as required) to update all stakeholders on upcoming deadlines, progress status, and any risk factors affecting timelines. Escalate any delays or deviations to the Regulatory Affairs Manager promptly.

5. Execution and Verification:

Responsible personnel must complete the required labeling tasks before the committed deadline. All updates or changes must comply with internal quality standards and regulatory guidelines. Completed tasks shall be reviewed and verified by Quality Assurance to confirm compliance.

6. Documentation and Record Retention:

All tracking records, communication logs, reports, and verification documents shall be archived electronically in accordance with GMP documentation control policies for future audit and review.

7. Deviation Handling:

If a deadline cannot be met, the deviation must be documented, root cause identified, corrective actions implemented, and approval obtained from Regulatory Affairs Manager. Revised commitments shall be updated in the tracking system accordingly.

8. Review and Continuous Improvement:

The SOP and tracking process shall be reviewed periodically (at least annually) by the Regulatory Affairs Head to identify improvement opportunities. Lessons learned from missed deadlines or deviations will drive process enhancement and training updates.

Abbreviations

RA – Regulatory Affairs
QA – Quality Assurance
SOP – Standard Operating Procedure
GMP – Good Manufacturing Practice
PI – Product Information

Documents

Essential documentation required for this SOP includes:

1. Labeling Commitments Tracking Log (Annexure-1)
2. Labeling Deadlines Escalation Report (Annexure-2)
3. Labeling Commitment Deviation Form (Annexure-3)

References

1. ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
2. FDA 21 CFR Part 211 – Current GMP for Finished Pharmaceuticals
3. EU Guidelines for Good Manufacturing Practice for Medicinal Products
4. Internal Quality Management System Documentation Control Procedures
5. Company Policy on Regulatory Submissions and Labeling Compliance

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Labeling Commitments Tracking Log

Purpose: To systematically record all labeling commitments, deadlines, and responsible persons for regulatory and client-driven labeling activities.

Commitment ID	Description	Product Code	Deadline	Responsible Person	Status	Remarks
LC-2026-001	Submit updated artwork per agency comments	PC-105	30/04/2026	Regulatory Exec	In Progress	Awaiting final approvals
LC-2026-002	Update leaflet translations for Germany market	PC-208	10/05/2026	Regulatory Exec	Not Started	Translation vendor notified

Annexure-2: Labeling Deadlines Escalation Report

Purpose: To document escalations related to potential or actual missed deadlines and track corrective action progress.

Escalation ID	Commitment ID	Date of Escalation	Issue Description	Action Taken	Status
ESC-2026-01	LC-2026-001	25/04/2026	Delay in artwork approval process	Reminder sent to artwork team, expedited review requested	Ongoing

Annexure-3: Labeling Commitment Deviation Form

Purpose: To formally record and manage deviations from agreed labeling commitments, including root cause analysis and corrective actions.

Deviation No.	DEV-2026-001
Commitment ID	LC-2026-002
Date of Deviation	11/05/2026
Description of Deviation	Translation delayed beyond committed deadline due to vendor issues
Root Cause	Vendor resource shortage
Corrective Action	Engaged alternate vendor and revised timeline
Approval Status	Pending
Reviewed By
Approved By

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
15/04/2026	1.0	Initial issue	New SOP creation